GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Maven Brands Inc (XCNQ:MJ) » Definitions » Risk Assessment

Maven Brands (XCNQ:MJ) Risk Assessment


View and export this data going back to 2015. Start your Free Trial

What is Maven Brands Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Maven Brands is: No Data: Cannot be evaluated.

Competitive Comparison of Maven Brands's Risk Assessment

For the Drug Manufacturers - Specialty & Generic subindustry, Maven Brands's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Maven Brands's Risk Assessment Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Maven Brands's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Maven Brands's Risk Assessment falls into.


Maven Brands  (XCNQ:MJ) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Maven Brands Risk Assessment Related Terms

Thank you for viewing the detailed overview of Maven Brands's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Maven Brands (XCNQ:MJ) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Maven Brands Inc (XCNQ:MJ) » Definitions » Risk Assessment
Comparable Companies
XCNQ:IBH XCNQ:PLNT.X XCNQ:OVAT XCNQ:GSL XCNQ:BIO TSXV:NU XCNQ:SE XCNQ:XCX XCNQ:MJRX XCNQ:GHG ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
100 Kalamalka Lake Road, Unit 32, Vernon, BC, CAN, V1T 9G1
Website
https://www.mavenbrands.ca
Maven Brands Inc is a licensed producer of medicinal cannabis for the Canadian market under Canada's Marihuana for Medical Purposes Regulations program administered by Health Canada. The company is launching an innovative services program to provide seed-to-shelf solutions for cannabis micro-cultivators and small-scale producers across Canada. Its services will be designed to support craft growers on a path to the regulated market and will operate from the True Leaf Campus facility located in Lumby, British Columbia.